Prospective evaluation of a telmisartan suppression test as a diagnostic tool for primary hyperaldosteronism in cats.
Maxime KurtzVirginie FabrèsRenaud DumontValérie ChetboulSabine ChahoryVittorio SaponaroEmilie TrehiouCamille PoissonnierPeggy PassavinColine JondeauMatthieu BottThierry BuronfosseGhita BenchrekrounPublished in: Journal of veterinary internal medicine (2023)
The oral telmisartan suppression test using a single dose of 2 mg/kg telmisartan did not discriminate cats with PHA from healthy middle-aged cats or cats with diseases that may result in secondary hyperaldosteronism.
Keyphrases